➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Colorcon
Medtronic

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALITRETINOIN

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Alitretinoin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002188 A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals Phase 2 1969-12-31 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002188 A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research Phase 2 1969-12-31 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002439 A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals N/A 1969-12-31 The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00002439 A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research N/A 1969-12-31 The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Alitretinoin

Condition Name

Condition Name for Alitretinoin
Intervention Trials
Hand Dermatoses 3
Eczema 2
HIV Infections 2
Sarcoma, Kaposi 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Alitretinoin
Intervention Trials
Eczema 6
Dermatitis 4
Sarcoma 3
Skin Diseases 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Alitretinoin

Trials by Country

Trials by Country for Alitretinoin
Location Trials
United States 32
Germany 11
Canada 6
Netherlands 3
Denmark 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Alitretinoin
Location Trials
District of Columbia 1
New York 1
Georgia 1
Idaho 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Alitretinoin

Clinical Trial Phase

Clinical Trial Phase for Alitretinoin
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Alitretinoin
Clinical Trial Phase Trials
Completed 11
Recruiting 3
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Alitretinoin

Sponsor Name

Sponsor Name for Alitretinoin
Sponsor Trials
Basilea Pharmaceutica 6
Anderson Clinical Research 2
Ligand Pharmaceuticals 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Alitretinoin
Sponsor Trials
Other 15
Industry 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Baxter
Johnson and Johnson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.